胎盘植入性疾病患者血清PLGF、PAPP-A水平与植入深度及产后出血的关系

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1086 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the relationship between the levels of serum placental growth factor (PLGF), pregnancy-related plasma protein A (PAPP-A), implantation depth and postpartum hemorrhage in patients with placental implantable disease (PAS). Methods A total of 228 PAS patients (PAS group) admitted to No. 971 Hospital of PLA Army from June 2018 to June 2023 were selected and divided into adhesion group (77 cases), implantation group (88 cases) and penetration group (63 cases) according to placental implantation depth, and 217 pregnant women with normal delivery during the same period were selected as control group. The levels of Serum PLGF and PAPP-A were detected, postpartum hemorrhage of PAS patients was analyzed, and the relationship between PLGF, PAPP-A, PAS implantation depth and postpartum hemorrhage was analyzed. Results The levels of serum PLGF[(509.64±127.48)pg/ml vs. (356.12±101.24)pg/ml] and PAPP-A [(4 216.32±623.19)mU/L vs. (3213.54±305.43 )mU/L]in PAS group were higher than those in control group (P<0.05), and the levels of serum PLGF and PAPP-A in penetration group were higher than those in implant group and adhesion group (P<0.05). High level of PLGF and high level of PAPP-A were risk factors for PAS postpartum hemorrhage (P<0.05). The areas under the curve of PLGF and PAPP-A in predicting postpartum hemorrhage of PAS were 0.863 and 0.980, both of which had high value (P<0.05). Conclusions The increase of serum PLGF and PAPP-A levels in PAS pregnant women is associated with the increase of placenta implantation depth and the risk of postpartum hemorrhage. The detection of serum PLGF and PAPP-A levels is helpful to predict the postpartum hemorrhage in PAS.

Key words： pernicious placenta previa placenta accreta spectrum postpartum hemorrhage placental growth factor pregnancy-associated plasma protein-A

Received: 10 June 2024

ZTFLH:

R714.462

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZANG Meichun
	ZHU Ping
	HU Haiyun
	WANG Yuanyuan
	LIN Sen

Cite this article:

ZANG Meichun,ZHU Ping,HU Haiyun等. Relationship between serum PLGF, PAPP-A levels and implantation depth and postpartum hemorrhage in PAS patients[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2025, 36(1): 21-24.

URL:

https://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR https://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2025/V36/I1/21

[1]	Zhao H, Wang Q, Han M,et al. Current state of interventional procedures to treat pernicious placenta previa accompanied by placenta accreta spectrum: a review[J]. Medicine (Baltimore), 2023,102(37):e34770.
[2]	Zhou Y, Song Z, Wang X,et al. Ultrasound-based nomogram for postpartum hemorrhage prediction in pernicious placenta previa[J]. Front Physiol,2022,13:982080.
[3]	Chau K, Hennessy A, Makris A. Placental growth factor and pre-eclampsia[J]. J Hum Hypertens, 2017, 31(12):782-786.
[4]	王娜,张小环,陈丽珍,等.血清低氧诱导因子-1α、胎盘生长因子及妊娠相关血浆蛋白A检测对子痫前期的预测价值[J].中国临床医师杂志,2021,49(1):108-111.
[5]	谢真,陈益明,孙杨芳,等.早孕期血清妊娠相关血浆蛋白A和胎盘生长因子水平与子痫前期的相关性研究[J].中国妇幼保健,2020,35(16):2960-2963.
[6]	陈瑶,俞海平,王永红.胎儿生长受限孕妇子宫动脉、脐动脉血流指数与妊娠相关血浆蛋白关系及预测效能[J].中国计划生育学杂志,2022,30(3):703-706.
[7]	中华医学会妇产科学分会产科学组 .前置胎盘的临床诊断与处理指南[J].中华妇产科杂志,2013,48(2):148-150.
[8]	Horng H C, Lai M J, Chang W H,et al.Placenta accreta spectrum (PAS) and peripartum hysterectomy[J].Taiwan J Obstet Gynecol,2021,60(3):395-396.
[9]	吕俊刚,翟莉,刘金龙,等.妊娠期高血压患者胎盘组织中circRNA 表达差异及其潜在作用机制[J].武警医学,2024,35(4):329-334.
[10]	Lecarpentier É, Vieillefosse S, Haddad B,et al. Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia[J].Ann Biol Clin (Paris), 2016, 74(3):259-267.
[11]	祝淡抹,刘雪琼,卢丹.妊娠相关血浆蛋白A及胎盘生长因子预测子痫前期的研究进展[J]. 国际妇产科学杂志,2020,47(4):384-387.
[12]	Faraji A, Akbarzadeh J M, Bahrami S,et al. Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum[J]. J Obstet Gynaecol, 2022, 42(5):900-905.
[13]	Zhang F, Gu M, Chen P,et al. Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1/PLGF ratio[J]. Placenta, 2022, 124:48-54.
[14]	Ma J, Liu Y, Guo Z,et al. The diversity of trophoblast cells and niches of placenta accreta spectrum disorders revealed by single-cell RNA sequencing[J]. Front Cell Dev Biol, 2022, 10:1044198.
[15]	Rekowska A K, Obuchowska K, Bartosik M,et al. Biomolecules involved in both metastasis and placenta accreta spectrum-does the common pathophysiological pathway exist [J].Cancers (Basel), 2023,15(9):2618.
[16]	Buhimschi I A, Zhao G, Eln H Y,et al. Analytical Comparison of pregnancy-associated plasma protein-a (PAPP-A) immunoassays for biochemical determination of gestational age[J]. J Appl Lab Med, 2021,6(6):1517-1532.
[17]	Yanachkova V, Staynova R, Stankova T,et al. Placental growth factor and pregnancy-associated plasma protein-a as potential early predictors of gestational diabetes mellitus[J]. Medicina (Kaunas), 2023, 59(2):398.
[18]	雍敏婕,宋艳春,张惠鹃,等.妊娠早期血清妊娠相关血浆蛋白A联合子宫动脉舒张早期切迹在预测子痫前期中的价值[J].广东医学,2022,43(8):1005-1009.
[19]	鲁桂玲,刘爱华,王文琴,等.彩色多普勒超声联合血清PAPP-A、LRP-1对胎盘植入的诊断价值分析[J].生物医学工程与临床,2023,27(3):292-297.
[20]	Balkaş G, Çaglar T. Elevated first-trimester PAPP-A is a marker in high-risk pregnancies with an increased risk of placenta accreta in predicting adverse outcomes[J]. Eur Rev Med Pharmacol Sci, 2023,27(20):9955-9961.
[21]	Wang J, Liu S, Qin H M,et al.Pregnancy-associated plasma protein a up-regulated by progesterone promotes adhesion and proliferation of trophoblastic cells[J]. Int J Clin Exp Pathol, 2014,7(4):1427-1437.